Skip to main content

Table 1 Baseline clinical, demographic, and echocardiographic variables

From: Left ventricular diastolic function and cardiotoxic chemotherapy

Age (years)

54.92 ± 7.6

Female (%)

64 (80%)

BMI (kg/m2)

24.7 ± 3.5

Hypertension

46 (57.5%)

Diabetes

38 (47.5%)

Smoking

13 (16.25%)

Radiation therapy

42 (52.5%)

Stage

 1

14 (17.5%)

 2

48 (60%)

 3

17 (21.25%)

 4

1 (1.25%)

Echocardiographic parameters

Mean ± SD

Ejection fraction

64.92 ± 1.96

E/A

1.36 ± 0.138

DT (ms)

179.62 ± 8.92

IVRT (ms)

86.92 ± 4.53

e′ septal

10.6 ± 0.83

E ‘lateral

14.01 ± 0.806

E/e′ septal

9.21 ± 0.731

Peak TR velocity m/s

2.12 ± 0.287

GLS

− 18.81 ± 0.797

  1. E mitral inflow early diastolic velocity; A mitral inflow late diastolic velocity; DT deceleration time; IVRT isovolumic relaxation time; e′ mitral annular early tissue Doppler velocity; TR tricuspid regurgitation; GLS global longitudinal strain; MS mill seconds. Stage 1 localized cancer; Stage 2 early locally advanced; Stage 3 late locally advanced
  2. Stage 4 metastasis